Skip to content ↓

In the Media

Media Outlet:
Publication Date:

MIT spinout Ginkgo Bioworks has not only maintained its founding members, but also recently raised $275 million from investors, writes Matthew Herper for Forbes. Herper predicts that excitement surrounding synthetic biology companies will continue because “private money is getting excited about the idea of designing biology.” 

Related News

Ginkgo Bioworks staff members Ramya Prathuri (left) and Nate Tedford work at the mass spectrometer in the Ginkgo foundry.

Hacking microbes

Startup’s engineered yeast helps clients produce fragrances and flavors more efficiently.